文献速递基础与转化研究组学、生物样本库与精准医学

时序多组学揭示LRG1为转移的血管生态位引导因子

Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis.
PubMed 文献 · Sci Transl Med · 2021-09-01

本研究利用内皮细胞转录组学与血清蛋白组学,在肺转移手术模型中追踪转移性血管生态位的演变;发现原发肿瘤通过STAT3依赖方式系统性上调内皮LRG1,LRG1促进NG2+血管周细胞增多而推动转移,中和LRG1可延缓术后转移生长并提高总生存。

要点

  • 原发肿瘤系统性重编程血管内皮,使血管生态位成为转移前微环境。
  • LRG1是TGFβ通路相关因子,在原发肿瘤存在时经STAT3依赖方式在内皮细胞中系统性上调。
  • LRG1中和抗体术后辅助给药可延缓转移生长并提高总生存。

核心结论

  • 原发肿瘤诱导的血管内皮系统性改变构成转移前生态位,LRG1是其关键引导因子和潜在治疗靶点。

研究设计与样本

  • 采用肺转移手术模型,结合内皮细胞bulk与单细胞转录组学及血清蛋白组学进行时序多组学分析。
  • 对肺内皮细胞基因表达与分泌组进行比较分析,并在小鼠中进行LRG1功能干预实验。

主要发现

  • 原发肿瘤系统性重编程血管内皮以扰动稳态并为转移生长预置血管生态位。
  • 肺内皮细胞基因表达与分泌组比较分析鉴定LRG1为转移的早期引导因子。
  • 原发肿瘤存在时内皮细胞以STAT3依赖方式系统性上调LRG1。
  • 系统性上调LRG1通过增加促转移NG2+血管周细胞数量促进小鼠转移。
  • Lrg1基因缺失阻碍肺转移生长,术后辅助给予LRG1中和抗体延缓转移生长并提高总生存。

关键数值与推荐

  • 回顾性临床研究荟萃分析显示癌症患者血清LRG1浓度相应上调。

临床怎么用

  • LRG1可作为转移风险的候选血清标志物和术后辅助治疗靶点。

局限性

  • 研究基于手术模型和小鼠实验,临床转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Metastasis is the primary cause of cancer-related mortality. Tumor cell interactions with cells of the vessel wall are decisive and potentially rate-limiting for metastasis. The molecular nature of this cross-talk is, beyond candidate gene approaches, hitherto poorly understood. Using endothelial cell (EC) bulk and single-cell transcriptomics in combination with serum proteomics, we traced the evolution of the metastatic vascular niche in surgical models of lung metastasis. Temporal multiomics revealed that primary tumors systemically reprogram the body’s vascular endothelium to perturb homeostasis and to precondition the vascular niche for metastatic growth. The vasculature with its enormous surface thereby serves as amplifier of tumor-induced instructive signals. Comparative analysis of lung EC gene expression and secretome identified the transforming growth factor–β (TGFβ) pathway specifier LRG1, leucine-rich alpha-2-glycoprotein 1, as an early instructor of metastasis. In the presence of a primary tumor, ECs systemically up-regulated LRG1 in a signal transducer and activator of transcription 3 (STAT3)–dependent manner. A meta-analysis of retrospective clinical studies revealed a corresponding up-regulation of LRG1 concentrations in the serum of patients with cancer. Functionally, systemic up-regulation of LRG1 promoted metastasis in mice by increasing the number of prometastatic neural/glial antigen 2 (NG2)+ perivascular cells. In turn, genetic deletion of Lrg1 hampered growth of lung metastasis. Postsurgical adjuvant administration of an LRG1-neutralizing antibody delayed metastatic growth and increased overall survival. This study has established a systems map of early primary tumor-induced vascular changes and identified LRG1 as a therapeutic target for metastasis.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Singhal M, Gengenbacher N, Abdul Pari AA, et al. Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis. Sci Transl Med. 2021. PMID: 34516824. doi:10.1126/scitranslmed.abe6805

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。